These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21354550)

  • 41. Pelvic sidewall adenocarcinoma after definitive therapy for cervical adenocarcinoma in situ.
    Miller B; Dunn J; Dalrymple J; Krivak TC
    Gynecol Oncol; 2005 Nov; 99(2):489-92. PubMed ID: 16054200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
    Poynor EA; Marshall D; Sonoda Y; Slomovitz BM; Barakat RR; Soslow RA
    Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Stage distribution and survival rates in cervix cancer at the Gynecologic Clinic of the Debrecen Medical University from 1970 to 1980].
    Hernádi Z; Lampé L; Tóth MO; Juhász B
    Zentralbl Gynakol; 1984; 106(21):1424-31. PubMed ID: 6516635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An extremely rare case of adenoma malignum with large cystic tumor which resulted in urinary obstruction.
    Gotoh T; Kikuchi Y; Takano M; Kita T; Ogata S; Aida S; Anzai M
    Gynecol Oncol; 2002 Feb; 84(2):339-43. PubMed ID: 11812098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clearinghouse: transgender issues.
    Focus; 1998 Jan; 13(2):4-5. PubMed ID: 11365021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.
    Krivak TC; Retherford B; Voskuil S; Rose GS; Alagoz T
    Gynecol Oncol; 2000 May; 77(2):334-5. PubMed ID: 10785491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cytologic diagnosis of malignant tumors of the cervix].
    Shabalova IP; Martsishevskaia RL
    Lab Delo; 1991; (1):45-8. PubMed ID: 1714996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The definition of stage IA(1) cervical adenocarcinoma and selection criteria for nonradical surgical management.
    Schorge JO; Lee KR; Sheets EE
    Gynecol Oncol; 2000 May; 77(2):339-40. PubMed ID: 10785493
    [No Abstract]   [Full Text] [Related]  

  • 49. Postconization surveillance of cervical adenocarcinoma in situ. A prospective trial.
    Schorge JO; Lea JS; Ashfaq R
    J Reprod Med; 2003 Oct; 48(10):751-5. PubMed ID: 14619639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How valid are current cervical cancer prognostic factors that are used to recommend adjunctive radiation therapy after radical surgery?
    Creasman WT; Kohler M; Korte JE
    Am J Obstet Gynecol; 2009 Sep; 201(3):260.e1-3. PubMed ID: 19539891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Invasive adenocarcinoma of the cervix following Lletz for adenocarcinoma in situ.
    Townsend DE
    Gynecol Oncol; 1996 Feb; 60(2):332. PubMed ID: 8631562
    [No Abstract]   [Full Text] [Related]  

  • 52. [Sex reassignment surgery in a trans-sexual].
    Tsur H; Gilboa D; Borenstein A
    Harefuah; 1989 May; 116(10):509-11. PubMed ID: 2792921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. There is reason for optimism: an introduction to the special issue on research needs in transgender health and medicine.
    Safer JD; Coleman E; Hembree W
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):165-7. PubMed ID: 26910275
    [No Abstract]   [Full Text] [Related]  

  • 54. [Surgical gender reassignment in the elderly].
    Rossi Neto R; Vom Dorp F; Schenck M; Rübben H; Hess J
    Urologe A; 2012 Oct; 51(10):1414-8. PubMed ID: 23053037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inadequate psychological assessment for female to male gender reassignment.
    Nancarrow M
    Australas Psychiatry; 2011 Dec; 19(6):537-8. PubMed ID: 22077308
    [No Abstract]   [Full Text] [Related]  

  • 56. [The vulnerable health of transgender persons].
    Rebetez N; Volkmar E
    Krankenpfl Soins Infirm; 2014; 107(11):8-12, 52-5, 76-9. PubMed ID: 25438404
    [No Abstract]   [Full Text] [Related]  

  • 57. Is There Value to Seeing a Transgender Fellowship-Trained Surgeon?
    Salgado CJ; Nugent A; Kuhn J
    Plast Reconstr Surg; 2018 Jun; 141(6):978e-979e. PubMed ID: 29608521
    [No Abstract]   [Full Text] [Related]  

  • 58. Breast imaging in the transgender patient.
    Phillips J; Fein-Zachary VJ; Mehta TS; Littlehale N; Venkataraman S; Slanetz PJ
    AJR Am J Roentgenol; 2014 May; 202(5):1149-56. PubMed ID: 24758673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The growing and interdisciplinary field of transgender health.
    Irwig MS
    Andrology; 2021 Nov; 9(6):1677-1678. PubMed ID: 34817933
    [No Abstract]   [Full Text] [Related]  

  • 60. The surgical suite.
    Plemons E
    J Med Humanit; 2013 Jun; 34(2):245-7. PubMed ID: 23483367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.